Lexeo Therapeutics, Inc. (LXEO) Tops Q4 EPS by 59c

Lexeo Therapeutics, Inc. (NASDAQ: LXEO) reported Q4 EPS of ($0.27), $0.59 better than the analyst estimate of ($0.86).

For earnings history and earnings-related data on Lexeo Therapeutics, Inc. (LXEO) click here.

You May Also Be Interested In

• Lowe's (LOW) PT Lowered to $275 at Guggenheim
• HomeTrust Bancshares (HTB) PT Raised to $57 at Stephens
• Guggenheim Reiterates Neutral Rating on Advance Auto Parts (AAP)